Welcome to Cohesion Biosciences
Home > Product > Blocking Peptide
DYRK1B Blocking Peptide CBP5164
  • Western blot analysis of DYRK1B expression in Hela (A), HT1080 (B) whole cell lysates.
  • Immunohistochemical analysis of DYRK1B staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Product NameDYRK1B Blocking Peptide
Cat No: CBP5164
Source: Synthetic
Reactivity: H, M, B
Applications: BL
*Application Key:
E- ELISA, WB - Western blot, IH - Immunohistochemistry, IF - Immunofluorescence, FC - Flow cytometry, IC - Immunocytochemistry, IP - Immunoprecipitation, ChIP - Chromatin Immunoprecipitation, EMSA - Electrophoretic Mobility Shift Assay, BL - Blocking, SE - Sandwich ELISA, CBE - Cell-based ELISA, RNAi - RNA interference
*Species Reactivity Key:
H - Human, M - Mouse, R - Rat, B - Bovine, C - Chicken, D - Dog, G - Goat, Mk - Monkey, P - Pig, Rb - Rabbit, S - Sheep, Z - Zebrafish
Size
Price
1 mg
$100
5 mg
$300
Add to cart Ship in 3 weeks My orders
Description: The peptide is used to block Anti-DYRK1B Antibody (#CPA5164) reactivity.
Form: Lyophilized powder
Gene Symbol: DYRK1B
Alternative Names: MIRK; Dual specificity tyrosine-phosphorylation-regulated kinase 1B; Minibrain-related kinase; Mirk protein kinase
Entrez Gene (Human): 9149
Entrez Gene (Mouse) : 13549
SwissProt (Human): Q9Y463
SwissProt (Mouse) : Q9Z188
Purity : >85%
Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.
Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Storage/Stability : Shipped at 4°C. Store at -20°C for one year.
  • Western blot analysis of DYRK1B expression in Hela (A), HT1080 (B) whole cell lysates.
  • Immunohistochemical analysis of DYRK1B staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugacompact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
COHESION BIOSCIENCES LIMITED
Copyright © 2022 Cohesion Biosciences. All Rights Reserved